MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Cognition evaluation in patients following focused ultrasound thalamotomy for tremor

    I. Shifrin Senderova, I. Schlesinger, M. Nassar, A. Sinai, R. Haddad, I. Erikh, L. Shornikov, M. Constantinescu (Haifa, Israel)

    Objective: Evaluation of cognitive function before and following unilateral FUS VIM-thalamotomy in tremor patients. Background: VIM focused ultrasound (FUS) thalamotomy has established efficacy in tremor…
  • 2023 International Congress

    Impact of istradefylline on the onset of dyskinesia in Parkinson’s Disease patients with wearing off: a randomized controlled study (ODYSSEI)

    Y. Tsuboi, T. Hasegawa, Y. Shimo, S. Kaneko, M. Tomiyama, K. Kashihara, S. Chiu, T. Yamaguchi (Fukuoka, Japan)

    Objective: To determine the effect of long-term treatment with istradefylline (IST) on the time to onset of dyskinesia in Parkinson’s disease (PD) patients with wearing-off…
  • 2023 International Congress

    Imaging the noradrenergic system in Parkinson’s disease: A [11C]Yohimbine PET and neuromelanin MRI study

    C. Laurencin, S. Lancelot, M. Huddlestone, S. Brosse, I. Merida, N. Costes, J. Redouté, S. Thobois, P. Boulinguez, B. Ballanger (Lyon, France)

    Objective: To assess two aspects of the noradrenergic system using multimodal in vivo imaging in a sample of Parkinson’s disease (PD) patients and healthy controls…
  • 2023 International Congress

    Mosaic divergent repeat interruptions in X-linked dystonia-parkinsonism: stability over generations and time

    J. Laß, T. Lüth, K. Schlüter, RL. Rosales, RD. Jamora, G. Saranza, CCE. Diesta, S. Schaake, B. Laabs, N. Brüggemann, I. König, C. Klein, A. Westenberger, J. Trinh (Lübeck, Germany)

    Objective: This study aims to investigate the stability of Mosaic Divergent Repeat Interruptions affecting motif Length and Sequence (mDRILS) frequencies and repeat length across generations…
  • 2023 International Congress

    Discriminative properties and sensitivity to change of three cognitive assessment instruments in Huntington’s disease

    A. Horta-Barba, S. Martinez-Horta, J. Pérez-Pérez, A. Puig-Davi, N. de Lucia, G. de Michele, E. Salvatore, S. Kehrer, J. Priller, S. Migliore, F. Squitieri, A. Castaldo, C. Mariotti, V. Mañanes, J. Lopez-Sendon, N. Rodriguez, A. Martinez-Descals, F. Júlio, C. Januário, M. Delussi, M. de Tommaso, S. Noguera, J. Ruiz-Idiago, E. J. Sitek, R. Wallner, A. Nuzzi, J. Pagonabarraga, J. Kulisevsky, HD. Disease Network (BARCELONA, Spain)

    Objective: We addressed and compared the discriminative properties of different cognitive instruments, and we determined the sensitivity to change of the proposed assessments in the…
  • 2023 International Congress

    Nocturnal behavior of people with Parkinson’s disease

    C. Duval, A. Karelis, J. Daneault (Montreal, Canada)

    Objective: Compare the nocturnal energy expenditure (kcal) and activity behavior of people with PD using a real-time wearable sensor, and determine whether these outcomes differed…
  • 2023 International Congress

    Functional circuit abnormalities in Levodopa-induced dyskinesia in Parkinson’s disease: A systematic review

    B. Thomsen, M. Vinding, D. Meder, L. Marner, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

    Objective: Levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD) are involuntary movements caused by long-term treatment with dopaminergic replacement therapy (levodopa). During the cause of PD,…
  • 2023 International Congress

    Atypical parkinsonism and psychiatric disorder in hereditary diffuse leukoencephalopathy with spheroids: a novel variant in the CSF1R gene

    M. Gea, B. Flores-Pina, D. Vilas-Rolan, A. Castillo-Gandia, C. Carrato-Moñino, K. Beyer, M. Paré-Curell, A. Massuet, L. Ispierto-González (Badalona, Spain)

    Objective: We describe the clinical, radiological and neuropathological phenotype of a patient carrying a novel variant in the CSF1R gene. Background: Hereditary diffuse leukoencephalopathy with…
  • 2023 International Congress

    PSP-like phenotype triggered by STN DBS in PD: a case report

    W-H. Chang, Y-C. Chen, P-L. Chen, P-H. Tu, C-H. Yeh, T-C. Liu, C-S. Lu, C-C. Chen (Taoyuan, Taiwan)

    Objective: We report on a patient with Parkinson’s disease (PD) who developed reversible Progressive Supranuclear Palsy (PSP) like phenotype after bilateral subthalamic nuclear (STN) deep…
  • 2023 International Congress

    Normative data for the Vietnamese smell identification test

    T. Dang, K. Vo, U. Ha, Q. Ly, T. Thai, T. Nguyen, T. Tran (HO CHI MINH, Viet Nam)

    Objective: This study aimed to investigate the normative value of the VSIT in different age groups and genders Background: The Vietnamese smell identification test (VSIT)…
  • « Previous Page
  • 1
  • …
  • 222
  • 223
  • 224
  • 225
  • 226
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley